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Abstract
Circulating microRNA are promising diagnostic and prognostic biomarkers of disease in 
quantitative blood tests. A label-free, PCR-free, electrochemical microarray technology on a 
monolith electrode is described, with 10 attomolar (aM) sensitivity and responsiveness to binding 
of <1 zeptomole of target to immobilized ssDNA probes with zero background. Specificity is 
100% in a mixture with five nonspecific miRNA each with a 103-fold higher concentration. Direct 
measurement on plasma-derived miRNA without cDNA conversion and PCR demonstrated 
multiplexing and near-ideal quantitative correlation with an equivalent pure sample. The dynamic 
range is a target concentration ranging from 10–2 to 103 femtomolar (fM). This PCR-free novel 
technology can be applied as a test for cancer diagnosis/prognosis to detect 103 copies of a 
miRNA sequence in RNA extracted from 100 μL of plasma.
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Cell-derived circulating microRNA (miRNA) in blood, urine, and saliva could be utilized to 
develop a blood test for the diagnosis of diseases and for personalized therapy. It was 
recently discovered that most circulating miRNAs in blood are cell free and are remarkably 
stable in body fluids because of complexation with argonaute proteins,[1] making them 
attractive for screening and early detection of diseases, particularly cancer.[2,3] MiRNAs are 
noncoding ∼22 nucleotide (nt) long, single-stranded RNA (ssRNA) sequences that bind to 
mRNA by their 5’-seed region (2–8 nt long) to negatively regulate mRNA expression.[4] 
MiRNAs regulate ∼60% of genes involved in a range of cellular activities, such as cell cycle, 
proliferation, differentiation, metabolism, inflammation, and immune response.[5,6] As one 
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miRNA can regulate multiple mRNAs and multiple miRNAs can regulate a single mRNA,[7] 
a panel of miRNA is required to diagnose cancer at high specificity.[8] Meta-analyses for a 
variety of cancers, for example, colorectal,[9] lung,[10] and pancreatic[11] cancer, suggest that 
profiling dysregulation of several miRNA sequences can lead to diagnosis at over 85% 
sensitivity and specificity. Thus, the challenge in developing a screening test is to 
quantitatively profile a panel of miRNA sequences with proper controls[12] at a sensitivity of 
∼10 copies in RNA extracted from a ¼L of blood[13] over a dynamic range of five orders.[14]
The small size of miRNAs (unfortunately) leads to large variations in melting temperature 
due to small differences in sequence, making it difficult to multiplex a large number of 
sequences using qPCR, the gold standard.[15] Furthermore, synthesis of cDNA from miRNA 
by reverse transcriptase (RT) requires ∼105 copies for efficient conversion.[16,17] Hence, 
RNA from ∼10 mL of plasma is required to detect 10 copies in extracted RNA. To avoid 
PCR, several approaches have been developed to obtain a limit of detection (LOD) in the fM 
to aM range: the nanopore translocation method,[18] an electrochemical transistor made from 
nanowires,[19] surface plasmon resonance in nanoprisms,[20] and differential pulse 
voltammetry from nanoelectrodes,[21] which have reported LODs of 100 fM, 1 fM, ∼40 aM, 
and 100 aM, respectively. A chip with a nano-electrode array has been shown to directly 
measure multiple miRNA sequences from plasma without the cDNA conversion and PCR.
[22]
 The analysis is usually non-absolute, requiring a difference in signals before and after 
the binding between the probe and the target miRNA,[19–22] which may amplify error. 
Individual drops on each microspot need to be placed to confine the diffusion length,
[19,21,22]
 which may limit the device density and result in possible error due to solvent 
evaporation.
In this study, an electrochemical microarray patterned on a monolith electrode was 
developed resulting in robust statistics. To gain high sensitivity, a method was developed to 
focus ∼1,800 molecules to microarray spots from ∼0.3 mL solution and measure <1 
zeptomole target-to-probe binding. The combination allowed the technology to obtain 
sensitivity of 10 attomolar (i.e., ~0.15fg/¼L) with 100% specificity over a dynamic range of 
five orders of magnitude. The unique feature not shown before is absolute signal with zero 
background, i.e., the signal for no binding is zero (which was confirmed for every chip).
For the study, using a 1.2 by 1.2 cm chip with five longer and two shorter (control) 
electrodes, an array of seven and three 50-¼m holes (i.e., spots) were patterned on a 
photoresist, respectively, using photolithography (see Figure 1a and Sections S.1 and S.2 of 
the Supporting Information (SI) for details). Single-stranded DNA (ssDNA) probes with 
thio-terminated sequences were immobilized on the spots of an exposed Au electrode 
(Section S.3). The binding was performed in a solution of target molecules in 100 mM of 
phosphate buffer (PB) with 50 mM of auxiliary ion [Fe(CN)6]4– by cyclic voltammetry (CV) 
(Figure 1b). The CV ramp potential (V) applied between the working electrode (WE) and 
the reference electrode (RE) was from –0.4 to 0.3 V at a ramp rate of 50 mV/s. The amount 
of binding on each of the five electrodes was controlled by the number of cycles, N. 
Importantly, although the electric-field-influenced binding has been demonstrated before,[23] 
the novelty here is the significant enhancement in binding due to the inclusion of redox ion, 
[Fe(CN)6]4–. As the positive potential attracts the negatively charged target molecules, 
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beyond + 220 mV, [Fe(CN)6]4– oxidizes to [Fe(CN)6]3– causing the EDL to discharge to 
enhance the electric field penetration from 102 nm (at no redox) to typically 100 ¼m (during 
redox reaction).[24,25] The deeper penetration of the electric field is independently shown by 
differential interferometry where the ion oscillation was significantly enhanced, leading to a 
peak at V close to redox.[25,26] The binding process is called electrochemical redox 
enhanced binding (EREB). The effect of [Fe(CN)6]4– on binding efficiency is discussed 
later. Subsequent to vigorous washing, the uncovered area of the electrode was coated with a 
monolayer of mercaptohexanol (MCH) at 37 °C (SI, Sections S.1 and S.4).
Binding of targets to an array of probes on a monolith electrode was measured 
electrochemically by scanning a laser. It is known that methylene blue (MB) undergoes 
redox by specifically binding to the probe-target duplex by electron transport through π-π 
stacked base pairs.[27] A differential reflectometer was designed and developed to measure 
local redox of MB on each microarray spot on the electrode (Figure 1c). Reflectivity 
measurements were performed in 100 mM of PB containing 10 ¼M of MB and 50 mM of 
[Fe(CN)6]4–. The latter is the mediator for MB redox.[27] The reflectivity was performed 
during CV with a potential (E) from –0.5 to 0.1 V to cover the redox of MB (at ~−0.2 V). To 
measure differential reflectivity, a periodic AC potential of frequency, ω =2 KHz, and an 
amplitude of 100 mV was added to the CV ramp. The detector measured a DC signal 
corresponding to incident intensity, RO, and an AC signal at ω due to oscillation in the 
reflected light intensity caused by the oscillation of the ions due to the AC potential at ω 
(see SI, Section S.5 for the mechanism). The amplitude of the AC signal, RA, was obtained 
from the lock-in amplifier tuned to ω to measure differential reflectivity, R = RA/RO, as low 
as 0.001 %.
Typical raw data on a spot with ssDNA probe, P155, that specifically binds to target T155 
(ssDNA equivalent of miR155), showed oxidation and reduction peaks for MB (Figure 1d). 
The peaks were because the ion oscillation was maximum for E at maximum redox currents 
owing to deeper penetration of the electric field into the solution caused by discharge of the 
EDL.[25,26] As R corresponds to charge at the interface, the reflectometer is called a 
scanning electrometer for electrical double layer (SEED). Superposing the various cycles of 
R(t) and filtering the high frequency noise, the average reflectivity, <R> (E), was obtained 
from ~20 cycles (Figure 1e and Figure S5 in SI). The small error halo indicated that the 
oscillation of R was highly periodic leading to statistically robust Rmax. As the signal is a 
reduction of MB, Rmax is defined with respect to the reduction peak. The signal has a 
baseline because of ubiquitous oscillation of the ions due to AC potential at 2 KHz at all 
potentials, E, related to the optical properties of the solution (see SI, Equation (4)). All 
subsequent data presented is after baseline subtraction on the reduction peak. Importantly, 
on the same electrode, the spot with a nonspecific probe (i.e., P21) showed no MB redox 
peak. Thus, the specificity from differential reflectivity was 100%. The specificity was 
confirmed for each electrode on the chip. Specificity in a more aggressive environment is 
described in Figure 3.
The control electrode incorporated in every chip is an important unique feature of this 
method. No potential was applied during EREB on the shorter control electrodes. Each 
control electrode had a blank (i.e., bare Au) spot and one spot each with immobilized P155 
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and P21. All spots were covered with an MCH monolayer after EREB. For good quality 
data, all of the six spots on the two control electrodes should show no redox. A signal on the 
blank spot indicates poor MCH filling which would lead to poor specificity where the signal 
could erroneously estimate target copies by as high as 3-fold (SI, Section S.6). Importantly, 
the spots with P155 and P21 probes on the control electrode should show no redox 
indicating that the signal is zero, if no binding occurs (i.e., ssDNA in Figure 1e). Thus, the 
Rmax reported will be an absolute measurement of the amount of specific binding. The 
absolute nature of the signal ensured for every chip is a unique feature of the method not 
reported before.
At constant, N, as expected, E versus <R> (at N = 20) showed a monotonic decrease in the 
overall signal as the concentration decreased from 1 pM to 0.1 fM (Figure 2a). By increasing 
N from 20 to 32 cycles, the binding increased significantly to observe a signal from a target 
concentration of 0.01 fM (Figure 2a). Rmax at constant N (= 20) increased linearly (at a 
fitness of 97%) with a target concentration on a logarithmic scale of over four orders of 
magnitude (Figure 2b). Each Rmax in the calibration curve for N = 20 and 32 (Figure 2b) 
was an average of over 15 points (i.e., three points with a 6 ¼m laser beam on each of the 
five 50 ¼m spots on the electrode). Thus, five target concentrations were measured on each 
chip. The error bar was the standard deviation. The small error bar indicated excellent 
uniformity of immobilization, and reproduce bility of the measurement. Extrapolation to 
Rmax = 0 (Figure 2b) indicated that the LOD for N = 20 and 32 was ~ 16 aM and 3.9 aM, 
respectively. The practical sensitivity for the study was 10 aM or 0.15fg/¼L. For 0.3 mL 
solution during EREB, 10 aM corresponded to ~1,800 molecules. Uniform binding of over 
five array spots, implied that SEED can detect binding of <360 target molecules, i.e., a 
responsivity of <1 zeptomole.
Using SEED, the nature of the EREB process was characterized. Due to the increase in a 
larger penetration depth due to oxidation of [Fe(CN)6]4– noted above, the Rmax increased 
from ~0.3 × 10–4 to 1.3 × 10–4 for 1 fM of target due to the addition of 50 mM [Fe(CN)6]4– 
during the EREB process at N = 32 cycles (Figure 2c). Based on Figure 2a, this remarkable 
increase in Rmax by 1 × 10–4 due to inclusion of [Fe(CN)6]4– was equivalent to an increase 
in target concentration by tenfold. As the V ramped to negative values, the loosely attached 
target molecules were repelled to reactivate the probes. The negative potential of V = –0.4 V 
was sufficient for efficient repulsion of the nonspecific target to obtain the observed 100% 
specificity.
Three types of samples were studied to evaluate multiplexing and specificity in complex 
systems. First, a synthetic mixture of miR155 (1 fM) and miR21(10fM) in a background of 
five miRNA each with a concentration of 1 pM (sequences and more detail shown in SI, 
Section S.7) was analyzed on a chip at different N (Figure 3a). The Rmax for T155 was 
consistent with values in Figure 2b, indicating no interference from the background. The 
Rmax for T21 was higher than for T155 and was also consistent with a higher concentration. 
Thus, EREB/SEED can quantitatively measure multiple sequences in significantly larger 
background.
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Second, RNA was extracted from 200 ¼L of plasma from a healthy donor and spiked with 
C. elegans miR39a. After reconstituting the RNA in 300 ¼L of PB buffer, EREB was carried 
at 4°C to avoid RNA degradation. The Rmax for miR39a in buffer (i.e., calibration curve) 
was measured (Figure 3b) and compared to Rmax spiked in plasma for a concentration 
ranging from 10 aM to 1 pM (Figure 3b, inset). The correlation was remarkable, showing 
that the effect of background due to other molecules in plasma is negligible. Because it is 
possible to measure ~200 copies of target (i.e., 10 aM in 300 ¼L) extracted from 200 ¼L of 
plasma, the method can safely measure ~103 copies of (specific) miRNA extracted from 100 
¼L of plasma at zero background.
Third, to demonstrate multiplexing and quantitative comparison to qPCR, RNA was 
extracted from the plasma of a colorectal cancer patient (CRC) and a normal donor (ND) 
and spiked with miR39 of C. elegans. The copy number of each miRNA was normalized 
with respect to Rmax for a miR39a spike in the extracted RNA (using the calibration curve 
for SEED (Figure 3)) and the standard qPCR curve (SI, Figure S8). In all cases, the 
dysregulation by SEED and qPCR was consistent; and the relative copy numbers were 
quantitatively comparable (Figure 3c). For miR34a, the values were in the opposite direction 
because the copy number was close to spiked miR39a; however, the magnitudes were 
comparable (see SI, Section S.8 and Table).
In summary, we report a novel technology to electrochemically measure binding on a 
microarray patterned on a monolith electrode. The sensitivity is 10 aM (i.e., ~0.15 fg/¼L) 
with a limit of detection of ~3.9 aM at 100% specificity and a dynamic range of five orders 
of magnitude with robust statistics. By spiking plasma with miRNA, a direct analysis from 
extracted RNA without PCR and cDNA conversion was illustrated with remarkable 
correlation from 10 aM to 1 pM of spiked miR39a. Multiplexing on a single chip was 
demonstrated by directly measuring five miRNA plus one negative control for RNA 
extracted from 200 ¼L of plasma from a healthy donor and a cancer patient. The 
comparison to qPCR was quantitative for all of the miRNA targets. This label-free 
technology could be implemented as a tool for prognostic and diagnostic application.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. 
a) The electrodes and circuitry are on an approximately 200 nm thick SiO2 layer on Si. The 
etched photoresist (SU8) exposes the underlying electrode (cross-section A–A’, not to 
scale). The shorter electrodes are controls, where no EREB potential is applied. b) The 
EREB setup is a three-electrode system controlled by a potentiostat (AutoLab PGSTAT302 
N). The RE and CE are Ag/AgCl and Pt wire, respectively. A potential, V, is applied 
between the chip electrode (WE) and RE; and current, I, is measured between the WE and 
the CE. c) The differential reflectivity is measured during CV. As the potential, E, is ramped 
between the WE and the RE, the modulation in reflected light intensity, RA, at ω is 
amplified by the lock-in amplifier. The incident light intensity, RO measured as a DC signal. 
d) Raw data: R and E as a function of time, t (for specific binding); the full scan is shown in 
Figure S5. e) E versus R with “error halo” corresponding to cycle-to-cycle variations. The 
ssDNA is R from a spot with P155 on the control electrode not subjected to EREB. The 
nonspecific spot corresponds to the spot with P21 on the same electrode as the specific 
spots. Rmax is defined for the reduction peak with respect to the baseline.
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Figure 2. 
a) Typical baseline-corrected E versus <R> for various miR155 target concentrations on the 
spot with P155 for EREB performed at N = 20. The LOD was 0.01 fM at N = 32 (right axis). 
b) Rmax as a function of target concentration. Each data point was averaged over 15 E versus 
<R> scans. All of the controls and the nonspecific spot had zero signals. c) Effect of 
auxiliary ions on reflectivity was measured on the same spot without removing the chip from 
the sample chamber. First the experiment with no [Fe(CN)6]4– (in PB buffer) was conducted, 
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followed by a vigorous wash with distill water before the second experiment containing 
[Fe(CN)6]4– in PB buffer.
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Figure 3. 
a) The Rmax on a chip for specific binding of miR155 and miR21 with five background 
miRNA each at 1 pM concentration. b) Comparison of Rmax for miR39a in standard EREB 
buffer and spiked in extracted RNA from plasma and reconstituted in identical buffer 
(plasma). Inset: Comparison of signal from pure and plasma samples with a miR39a 
concentration ranging from 0.01 to 103 fM. c) Comparison of patient and healthy plasma for 
four miRNA by qPCR and SEED (on a single chip).
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Supporting Information (SI) 
S.1 Overall summary of all the steps used in the technology
Further details on various steps described are in the various sections below. 
Chip Fabrication:  The microarray was made on a 1.2 by 1.2 cm Si chip with Au 
electrodes and accompanying circuitry for power and signal on ~200 nm SiO2 to provide 
an insulating surface. (Fig. 1(a)).  The chip was cleaned in acetone, water, and ethanol 
followed by O2 plasma and subsequently immersed in piranha solution for ~60 sec. The 
chip was dried by blowing clean N2 from a 0.2 μm filter. Photoresist SU8 (Microchem 
2025) was diluted by adding three times the volume of cyclopentanone which was spin 
cast on the chip at 3,000 rpm for 60 sec. to produce an ~ 500-nm thick film. The chip 
was prebaked for 45 sec. at 80 °C. The film was exposed to Xe light (300 W) for 45 sec. 
through a contact mask with a Cr metalized pattern on quartz. The chip was post-baked 
for 45 sec. at 80 °C and developed in Microchem SU8 developer. The chip was then 
washed with water/isopropanol for ~ 60 sec and hard baked at 140 °C for 2 hr. The 
resulting pattern on each electrode was a microarray of 50 µm holes exposing the 
underlying Au electrode. 
Probe Immobilization:  The immobilization on the spots was obtained by locally 
dispensing 5 µM solution of the probe in 1 M of phosphate buffer (PB) using an Arrayit® 
capillary pin with tip of ~20 µm (Fig. S2). The 5 nL solution dispensed on each spot was 
held by surface tension (Fig. S3). Each spot of the chip was exposed to the 
probe solution drop at 19 °C in a humidified chamber to avoid evaporation 
during the immobilization process for at least 16 hrs. The actual exposure was for only 
2 hrs. The chip was washed and the process repeated again to obtain higher 
immobilization density. All of the solutions and the washing were performed using 
RNAse-free water (Invitrogen). 
Electrochemical Redox-Enhanced Binding (EREB) Process:  Subsequent to 
vigorous washing, EREB was performed in a (10 aM to 1 pM) solution of target 
molecules in 100 mM of phosphate buffer (PB) with 50 mM of auxiliary ion [Fe(CN)6]4-
by cyclic voltammetry (CV). The CV ramp potential (V) applied between the working 
electrode (WE) and the reference electrode (RE) was from -0.4 to 0.3 V at a ramp rate 
of 50mV/s. As the positive potential attracts the negatively charged target molecules, 
beyond +220 mV, [Fe(CN)6]4- oxidizes to [Fe(CN)6]3- causing the EDL to discharge to
enhance the electric field penetration from 102 nm (at no redox) to typically 100 µm 
(during redox reaction).1,2 To note is that the electric-field-influenced binding has been 
demonstrated before.3 The novelty in this method is the significant enhancement in 
binding due to the inclusion of redox ion. The scanning range of EREB was optimized 
using SEED. 
MCH Filling Process:  The MCH coating was one of the critical aspects of the 
fabrication. The goal was to completely coat all of the exposed Au electrode surfaces 
after the the target binding step such that there was no signal on all of the three spots of 
the control electrode:  the blank spot and the two spots with (immobilized) P155 and 
P21. The control electrode was not subjected to EREB, thus the spots had no binding. A 
signal on the control electrode would imply that the quality of MCH is poor and the 
signal on the active electrodes (that were subjected to EREB) is not absolute. 
The MCH immobilization was performed in two steps. The chip was exposed to vapors 
from a 0.5 mL solution of 10 mM MCH in RNAse-free water (Invitrogen) at 37 °C for 
10 hr. The process is called atomic layer deposition (ALD). The chip was dry with no 
condensation of water during ALD.  After rinsing in autoclaved DI water, the chip was 
then immersed in a 1 mL solution of 10 mM MCH in 30% HPLC grade ethanol for 3 
hours with vigorous shaking at 100 rpm in an incubator at 37 °C. The chip was 
subsequently rinsed and immersed in solution for differential reflectivity measurement. 
All of the solutions and washing /rinsing was performed in RNAse-free water 
(Invitrogen). MCH filling is after the EREB process to obtain good binding. 
Differential Reflectivity Measurements (Scanning Electrometer for Electrical 
Double-layer (SEED)):  Differential reflectivity was performed during CV with a 
potential (E) from -0.5 to 0.1 V to cover the redox of MB (at ~ -0.2 V). A periodic AC 
potential of frequency, ω = 2 kHz, and amplitude of 100 mV were added to the CV 
ramp.  The detector measured a DC signal corresponding to incident intensity, RO, and 
an AC signal at ω due to oscillation in the reflected light intensity caused by the 
oscillation of the ions due to the AC potential at ω. The amplitude of the AC signal, RA, 
was obtained from the lock-in amplifier tuned to ω to measure differential reflectivity, R 
= RA/RO, as low as 0.001%. The peaks were observed in Fig. 1(e) because the ion 
oscillation was maximum for E at maximum redox currents owing to deeper penetration 
of the electric field into the solution.4 
qPCR Analysis:  Total RNA was extracted using a standard kit (RNeasy Plus kit from 
QIAGEN). The total RNA was converted to cDNA using First Strand Synthesis kit 
(Clontech Lab., Inc). SYBR™ Green method (Clontech Lab., Inc) was adopted to 
perform the cDNA synthesis and qPCR measurements on the qPCR machine 
(QuantStudio™ 3 RT-PCR, ABI, USA). Briefly, 3.75 μL of a standard solution with known 
concentration was added to reverse transcriptase buffer and enzyme (the final reaction 
volume was 10 μL). The reaction was allowed to incubate at 37 OC for one hour, 
followed by denaturation of the RT enzyme at 85 OC for five minutes. The synthesized 
cDNA was diluted by 10-fold. A 0.8 μL portion was added to the master stock (SYBR 
Advantage Premix, ROX, miRNA-specific 5' and 3' primers) resulting in the final volume 
of 10 μL. Melting curves on qPCR products were also generated to confirm specificity of 
the amplification. After qPCR, the data was analyzed while setting the threshold 
fluorescence to 0.059 arbitrary units. The threshold was set to a constant for biological 
replicates. Based on Ct values, the relative fold change in targeted miRNAs was 
calculated. Quantification of miRNA copy number was calculated from standard curve. 
For the standard curve, at least 106 copies are needed in the RT mix, consistent with 
the literature (see Fig. S9 in Section S.9).5  
S.2 Chip Fabrication 
The microarray was made on a 1.2 by 1.2 cm Si chip with Au electrodes and 
accompanying circuitry for power and signal (Fig. 1(a)).  The chip is passivated with 
~200 nm SiO2 to provide an insulating surface. The chip was coated with SU8 
photoresist to make seven and three 50-µm holes on the longer and shorter electrodes, 
respectively, using a standard photolithography process (Fig. S1). Briefly, the chip was 
cleaned in acetone, water, and ethanol followed by O2 plasma and subsequently 
immersed in piranha solution for ~60 sec. The piranha solution was freshly prepared by 
mixing H2SO4 in H2O2 at a volume ratio of 3:1, respectively. The chip was dried by 
blowing clean N2 from a 0.2 μm filter. Photoresist SU8 (Microchem 2025) was diluted by 
adding three times the volume of cyclopentanone which was spin cast on the chip at 
3000 rpm for 60 sec. to produce an ~500-nm thick film. The chip was prebaked for 45 
sec. at 80 °C. The film was exposed to Xe light (300 W) for 45 sec. through a contact 
mask with a Cr metalized pattern on quartz. The chip was post-baked for 45 sec. at 
80 °C and developed in Microchem SU8 developer for ~5 min. with intermittent 
sonication for 20 sec (three times in the process).The chip was then washed with 
water/isopropanol for ~60 sec and hard baked at 140 °C for 2 hr.  
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Figure S1:  Cross-sectional view of the 
chip defined by A-A' in Fig. 1(a). 
Broadly, the photolithography had the 
following steps:  (a) initial chip with 
electrodes; (b) after spin coating SU-8 
photoresist; and (c) the chip after 
exposure to light and development to 
obtain a pattern of etched holes.  
 
S.3 Probe Immobilization 
Two types of probes were utilized in the study:   
 P155:  5'-HS-(CH2)6-AAA- ACC CCT ATC ACG ATT AGC ATT AA 3' 
 P21:  5'-HS-(CH2)6-AAA-TCA ACA TCA GTC TGA TAA GCT A-3' 
The corresponding specific targets were: 
 miR-155: 5' TTA ATG CTA  ATC GTG ATA GGG GT 3'  
 miR-21:  5' TAG CTT ATC AGA CTG ATG TTG A 3' 
The immobilization on the spots was obtained by locally dispensing 5 µM solution of the 
probe in 1 M of phosphate buffer (PB) using an Arrayit® capillary pin (Fig. S2(a)). The 
capillary size of the pin was ~20 μm (Fig. S2(b), optical microscope image). The 5 nL 
solution dispensed on each spot was held by surface tension (Fig. S3). Each spot of the 
chip was exposed to the probe solution drop at 19 °C in a humidified chamber to avoid 
evaporation during the immobilization process for 2 hr. The chip was washed and the 
process repeated again to obtain higher immobilization density. All of the solutions and 
the washing were performed using RNAse-free water (Invitrogen). 
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Figure S2: (a) The dispensing 
process was a typical spotting 
method with the chip on a 
motorized x-y stage, and the 
capillary pin (optical 
microscope image in (b)) was 
fixed. The solution was 
dispensed on various spots by 
moving the chip.   
Figure S3: (a) One of the two 
etched 50-µm holes was covered 
with a solution of probe molecules. 
The dark region is the gap between 
the two electrodes. (b) A side view 
image of the drop confined by 
surface tension.  
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S.4 MCH Filling Process 
The MCH coating is one of the most critical aspects of the fabrication that decides the 
specificity and quality of measurement (see Section S.6 discussed later). The goal was 
to completely coat all of the exposed Au electrode surfaces after the the target binding 
step such that there was no signal on all of the three spots of the control electrode:  the 
blank spot and the two spots with (immobilized) P155 and P21. The control electrode 
was not subjected to EFIB, thus the spots had no binding.  
The MCH immobilization was performed in two steps. The chip was exposed to vapors 
from a 0.5 mL solution of 10 mM MCH in RNAse-free water (Invitrogen) at 37 °C for 
10 hr. The process is called atomic layer deposition (ALD). The chip was dry with no 
condensation of water during ALD.  After rinsing in autoclaved DI water, the chip was 
immersed in 1 mL solution of 10 mM MCH in 30% HPLC grade ethanol for 3 hours with 
vigorous shaking at 100 rpm in an incubator at 37 °C. The chip was subsequently rinsed 
and immersed in solution for differential reflectivity measurement. All of the solutions 
and washing /rinsing was performed in RNAse-free water (Invitrogen). 
  
 
 
 
 
 
 
S.5 Oscillation of Reflected Light  
Let (n1,k1) and (n2,k2) be the real and imaginary refractive index of the solution and 
electrode, respectively (Fig. S4), where ki = (λ/4π)αi (where αi is the absorption 
coefficient of the material at wavelength, λ, of the incident light). In the most simplified 
case, it is assumed that there is no concentration gradient, thus n1 is not a function of x. 
The assumption is not good; however, the analytical solution captures the principle of 
the measurement, i.e., the modulation of the reflectivity as average n1 oscillates due to 
applied potential on the electrode. From Fresnel's law, the reflectivity, r, at normal 
incidence is, 
 
 𝑟 = (𝑛1−𝑛2)−𝑖(𝑘1−𝑘2)
(𝑛1+𝑛2)−𝑖(𝑘1+𝑘2)
 (1) 
 
Thus, the magnitude of reflectivity is, 
 |𝑟|2 = |{(𝑛1
2−𝑛2
2)−(𝑘1
2−𝑘2
2)}
2
+4(𝑛1𝑘1−𝑛2𝑘2)
2
{(𝑛1+𝑛2)2+(𝑘1+𝑘2)2}2
|
2
 (2)  
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n2, k2
Figure S4: A schematic of the 
reflectivity kinematics defining 
the optical properties.  
 
The refractive index is given by, n1 = nw + (dn/dc)c, where c is a concentration of various 
ions, dn/dc is the corresponding differential refractive index, and nw is the refractive 
index of water.  The details of the second term are not so critical, however, because the 
polarizability of the anion is larger than the cation, the refractive index modulation of the 
former will dominate over the latter. For small modulation, n1 = nw + <(dn/dc)c> + 
(dn/dc)δc, where δc is the perturbation around the equilibrium concentration profile due 
to the AC potential at frequency, ω. Generally, δc = δcocos(ωt + α), where δco is the 
amplitude of the ion oscillation and α is the phase difference between the applied 
potential and the ion oscillation. The phase difference is primarily due to viscosity 
effects.  The details of the constants and the composition of the solution is not as 
critical.  The important aspect is the application of the AC potential the concentration 
oscillates. Thus, the optical property of the solution is, 
 
 𝑛1 = 〈𝑛𝑤 +
𝑑𝑛
𝑑𝑐
𝑐〉 + 𝐵𝑐𝑜𝑠(𝜔𝑡 + 𝛼) (3) 
 
where the first term in <...> is a time-independent quantity that will change with x and is 
complex in the sense it depends on concentration profiles of various ionic species. B is 
modified amplitude that includes δco and the differential refractive index.  As the interest 
is to measure change in B as a function of applied ramp potential, E, the chemical 
details of B are not critical.  
By substituting Equation (3) in (1) and linearizing with only first order terms, i.e., no 
higher order harmonics, 2ω, 3ω, and so on, the AC component of the reflectivity is, 
 
 𝑅 = 𝐾 + 𝑄𝛿𝑐𝑜 (4) 
 
where K and Q are based on time-independent (i.e., equilibrium) optical properties of 
the solution and the electrode. Importantly, the differential reflectivity has a baseline 
(i.e., K) signal.  The assumption of the linearity of the system is experimentally justified 
because the higher harmonics are over three orders of magnitude lower.  
The principle is that at redox, due to discharge in the interfacial layer caused by electron 
exchange, the field penetration increases. As a result δco increases during redox 
current.  Thus, from Equation (4), the potential, E, where R is maximum, will coincide 
with where the current due to oxidation and reduction reaction is highest.  
The typical oscillation of the amplitude of reflectivity (R) at the detector (see Fig. 1(c)) as 
a function of periodic applied bias (E) on the WE with respect to the solution showed 
good periodicity with respect to E cycles (Fig. S5). A small portion of the scan is shown 
in Fig. 1(d). 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
S.6 Effect of Incomplete MCH Coverage  
Every chip was tested for quality of MCH coverage by measuring the signal on the three 
spots on the control electrode that were not subjected to EREB potential.  The internal 
verification was critical to the quality of the data. The differential reflectivity 
Figure S5: Typical scan of R as a function of t due to applied periodic potential E(t). 
 
Figure S6: (a) Differential 
reflectivity from four spots when 
the MCH filling was not 
complete. The control (blank) 
shows complete MCH filling.  
 
-0.5 -0.4 -0.3 -0.2 -0.1 0.0 0.1
0
1
2
3
4
 Nonspecific (P21)
 Specific (P155)
 ssDNA (control)
 Blank (MCH, control)
Bias(E), Volts
<
R
>
, 
1
0
-4
Target (miR155): 1 fM
EFIB: N=32 cycles
0 10 20 30 40 50
0.0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
B
ia
s
 (
E
),
 V
o
lt
s
R
, 
1
0
-4
time (t), s
-0.6
-0.4
-0.2
0.0
0.2
N = 20 cycles
Target (miR155): 0.1 fM
EREB conditions
measurement performed on the three sets of spots on the two control electrodes was 
blank (Au electrode coated with MCH); the spot with P155 was filled with MCH (ssDNA); 
and the spot with P21 was filled with MCH (similar to ssDNA). In a chip with poor 
coverage, the blank and ssDNA show a peak due to MB redox due to pinholes (Fig. 
S6).  As a result, the signal from a nonspecific spot was also positive indicating the 
specificity was not 100% (Fig. S6). Interestingly, the signal from a specific spot (i.e., 
spot with immobilized P155) was over threefold higher compared to the signal if the 
specificity was 100% (Fig. 2(a)) due to redox through the pinholes in the MCH 
monolayer. Such a chip was rejected for the study. The analysis on the control was 
performed for every chip prior to making the measurements on the five larger 
electrodes. A signal on the control spots will lead to poor specificity, and the specific 
signal would erroneously be considered over 3-fold higher. The spots with P155 and 
P21 probes on the control electrode showing no redox indicated that the signal was 
zero, if no binding occurred (i.e., ssDNA in Fig. 1(e)).  Thus, the Rmax reported here is an 
absolute measurement of the amount of specific binding. MCH deposition was after 
EREB.  
 
S.7 Mixture Analysis 
A binary miRNA mixture was studied where the concentration of the nonspecific target, 
miR21, was 103-fold larger. The effect of background miR21 showed that the signal for 
specific binding of miR155 was unchanged (Fig. S8). On the same chip with EFIB at N = 
20, 28, and 32 (Fig. S8, inset), for the pure miR155 target (first bar for each N), the Rmax 
on the P21 spot was zero (hatched bar), indicating 100% specificity, while Rmax on the 
P155 spot (solid bar) was consistent with the calibration in Fig. 2(b). For each N, the 
signal for miR155 on the P155 spot (solid bar) was constant irrespective of the amount 
of miR21, indicating no interference from the latter. The signal for the 1 pM miR21 target 
on the P21 spot (third hatch bar for each N) was constant for all N, indicating saturation, 
as expected from Fig. 2(b).   
For mixture analysis, a synthetic nonspecific probe sequence that did not match any of 
the known homo sapiens (hsa) mRNA sequences was used for the study.  The 
sequence of the nonspecific probe was:  
5’ ThioMC6-D/ GCA ATA ATG CTC TTT TTC AT 3’ 
The sequences of the five background miRNA used for Fig. 3(a) were:  
miR 145:  5’ GTCCAGTTTTCCCAGGAATCCCT 3’ 
miR 29a:  5’ ACTGATTTTCTTTTGGTGTTCAG 3’  
miR 630:  5’ AGTATTCTGTACCAGGGAAGGT 3’ 
miR 34a:  5’ TGGCAGTGTCTTAGATGGTTGT 3’ 
miR 16-1: 5’ TAGCAGCACGTAAAATATTGGCG 3’ 
Targets, miR155 (1 fM) and 21 (10 fM), were measured simultaneously in a background 
of these five miRNA each with a concentration of 1 pM.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
S.8 QPCR and SEED Analysis of miR39a for C. Elegans 
The standard curve was obtained by making solutions of known amount of synthetic 
ssRNA of C. elegans miR39a (IDT, Inc., USA) target in sterile DNase/RNase-free water 
(Invitrogen, USA). SYBR Green method (Clontech Lab., Inc) was adopted to perform 
the cDNA synthesis and qPCR measurements on the qPCR machine (QuantStudio 3 
RT-PCR, ABI, USA). In brief, 3.75 μL of a standard solution with known concentration 
was added to reverse transcriptase buffer and enzyme (the final reaction volume was 
10 μL). The reaction was allowed to incubate at 37 OC for one hour, followed by 
denaturation of the RT enzyme at 85 OC for five minutes. The synthesized cDNA was 
diluted by 10-fold. A 0.8 μL portion was added to the master stock (SYBR Advantage 
Premix, ROX, miRNA-specific 5' and 3' primers) resulting in the final volume of 10 μL. 
Melting curves on qPCR products were also generated to confirm specificity of the 
amplification. After qPCR, the data was analyzed while setting the threshold 
fluorescence to 0.059 arbitrary units. The mean values of CT were plotted as a function 
number of copies provided for reverse transcription to synthesize the cDNA (Fig. S9).  
Thus, the CT value corresponds to the number of miR39a mixed in the 3.75 µL solution. 
The standard curve was fit to the linear region of the semi-log plot.  
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Figure S7: (a) Effect of background miR21 on <R> as a function of E on the same chip 
for specific binding to P155 and controls. Inset:  A histogram of Rmax for three chips 
measuring specific binding of a mixture to P155 and P21 spots. For each chip, EFIB was 
performed at three N each. The Rmax data for miR155 and mi21 targets were each 
averaged over 15 and 6 points, respectively. (b) Typical <R> as function of E on the 
same chip for specific binding to P155 and P21 spots and the controls. 
 
  
 
 
 
 
 
 
 
 
 
 
To demonstrate the sensitivity and specificity for a complex biological sample, about 
~14 µL of total RNA was extracted from ~200 µL of plasma from a healthy human 
subjects using a standard kit (RNeasy plus kit from Qiagen). The sample was 
reconstituted in 300 µL of PB buffer for EREB and spiked with synthetic miR39a of C. 
elegans at concentrations ranging from 0.01 to 103 fM. No miR39a is present in the 
human plasma sample. As the A-tail ligation, cDNA conversion and qPCR steps are 
avoided, direct binding of the miRNA to ssDNA probe is performed at 4 oC. For ssRNA 
(i.e., miRNA) as a target at low temperature, the EREB conditions are optimized to -
0.4V to 0.5 V.  Rmax increases monotonically as the concentration of spiked miR39a 
increases, however, the signal is typically twofold larger than for ssDNA targets in Fig. 
3(b). The signals from plasma (y-axis) and pure (x-axis) miR39a are literally identical 
along the 45o line (Fig. 3(b), inset). 
Further to demonstrate multiplexing, we detect the presence of four circulating miRNAs 
(155, 21, 630 and 34a) in plasma and compare SEED results with QPCR. To precisely 
determine the accuracy of SEED signal conversion to the miRNA copies, we estimated 
<Rmax> based relative fold change for different miRNA in the normal and colorectal-
cancer patient plasma samples, and compared with the gold standard PCR. The known 
amount of miR-39a (C. elegance miR control) was spiked in eluted RNA solution to the 
final concentration of 1 pM. Aliquot of the spiked RNA from the same RNA samples was 
used to perform SEED and PCR so that both procedures start with the same solution to 
avoid any statistical inconsistencies. 
We calculated the relative fold change of miRNA to 39a using the following equations: 
a) Relative fold change using PCR ~ 2∆𝐶𝑡 ~ [𝑚𝑖𝑅𝑁𝐴]
[39𝑎]
 
b) Relative fold change using SEED ~2𝑙𝑜𝑔210(∆𝑅𝑚𝑎𝑥) ~ [𝑚𝑖𝑅𝑁𝐴]
[39𝑎]
 
where,  [...] is molar concentration, which is equivalent to copy number. 
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Table: Comparative analysis of SEED and PCR based relative fold changes in multiple 
miRNAs of the normal and colorectal cancer patient plasma. 
 
S.No. Sequence SEED PCR SEED/PCR 
Rmax Fold change 
relative to 
miR-39a 
Ct values Fold change 
relative to 
miR-39a 
a) Normal Plasma 
1. miR-21 3.14 ± 0.26 14.76 ± 1.71 22.03 ± 0.48 13.61 ± 0.56 1.09 ± 0.14 
2. miR-34a 2.13 ± 0.33 0.69 ± 0.12 25.29 ± 0.28 1.41 ± 0.05 0.49 ± 0.09 
3. miR-155 0.88 ± 0.19 0.02 ± 0.003 29.66 ± 0.32 0.07 ± 0.003 0.22 ± 0.05 
4. miR-630 0.76 ± 0.23 0.01 ± 0.003 31.71 ± 0.13 0.02 ± 0.001 0.63 ± 0.20 
b) Patient Plasma 
1. miR-21 3.77 ± 0.26 99.72 ± 11.20 19.07 ± 0.75 105.64 ± 4.96 0.94 ± 0.12 
2. miR-34a 3.16 ± 0.35 15.80 ± 2.22 23.16 ± 0.45 6.20 ± 0.19 2.55 ± 0.37 
3. miR-155 0.92 ± 0.19 0.02 ± 0.003 30.28 ± 0.91 0.04 ± 0.002 0.38 ± 0.09 
4. miR-630 1.24 ± 0.25 0.04 ± 0.009 29.71 ± 0.46 0.07 ± 0.002 0.67 ± 0.14 
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